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A B S T R A C T
Background: It has been suggested that the risk of oesophageal adenocarcinoma might be increased in
patients with a history of eating disorders due to acidic damage to oesophageal mucosa caused by self-
induced vomiting practiced as a method of weight control. Eating disorders have also been associated
with risk factors for squamous cell carcinoma of the oesophagus, including alcohol use disorders, as well
as smoking and nutritional deﬁciencies, which have been associated with both main sub-types of
oesophageal cancer. There have been several case reports of oesophageal cancer (both main sub-types)
arising in patients with a history of eating disorders.
Methods: We used linked records of hospitalisation, cancer registration and mortality in Scotland
spanning 1981–2012 to investigate the risk of oesophageal cancer among patients with a prior history of
hospitalisation with eating disorder. The cohort was restricted to patients aged 10 years and <60 years
at the date of ﬁrst admission with eating disorder. Disregarding the ﬁrst year of follow-up, we calculated
indirectly standardised incidence ratios using the general population as the reference group to generate
expected numbers of cases (based on age-, sex-, socio-economic deprivation category-, and calendar
period-speciﬁc rates of disease).
Results: After exclusions, the cohort consisted of 3617 individuals contributing 52,455 person-years at
risk. The median duration of follow-up was 13.9 years. Seven oesophageal cancers were identiﬁed, as
compared with 1.14 expected, yielding a standardised incidence ratio of 6.1 (95% conﬁdence interval:
2.5–12.6). All were squamous cell carcinomas arising in females with a prior history of anorexia nervosa.
Conclusions: Patients hospitalised previously with eating disorders are at increased risk of developing
oesophageal cancer. Confounding by established risk factors (alcohol, smoking, and nutritional
deﬁciency) seems a more likely explanation than acidic damage through self-induced vomiting because
none of the incident cases of oesophageal cancer were adenocarcinomas, and because the study cohort
had higher than background rates of hospitalisation with alcohol-related conditions and chronic
obstructive pulmonary disease.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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jou r nal h o mep age: w ww.c an cer ep idem io log y.n et1. Introduction
It has been suggested that the risk of oesophageal cancer,
particularly adenocarcinoma, might be increased in patients with a
history of bulimia due to acidic damage to oesophageal mucosa
caused by self-induced vomiting practiced as a method of weight
control [1]. Estimates of the prevalence of self-induced vomiting* Corresponding author at: Public Health & Intelligence, NHS National Services
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4.0/).among patients with eating disorders vary according to the
population studied, but perhaps also because of a reliance on self-
reporting. Some of the highest estimates have emerged from an
international study of eating disorders in families, which reported
a prevalence of regular self-induced vomiting of 97% in purging
bulimia nervosa, 94% in anorexia nervosa and bulimia nervosa, 73%
in purging anorexia nervosa, 66% in bingeing anorexia nervosa, and
56% in eating disorders not otherwise speciﬁed [2].
Eating disorders have also been associated with smoking [3]
and alcohol use disorders [4,5] in some studies. Smoking has been
associated with both main sub-types of oesophageal cancer, and
alcohol with oesophageal squamous cell carcinoma [6]. In the
context of eating disorders, risk factors for oesophageal cancer maye under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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itself a probable risk factor for oesophageal cancer [6].
Oesophagitis has been reported in some patients with bulimia
[8]. In addition, there have been at least six case reports describing
seven patients with a prior history of bulimia [9–13] or
psychogenic vomiting [14] presenting subsequently with Barrett’s
oesophagus [9,14], adenocarcinoma of the oesophagus [9–11] or
proximal stomach [12], and squamous cell carcinoma of the
oesophagus [13,14]. In a cohort of patients with anorexia nervosa
(n = 524) diagnosed in north-east Scotland between 1965 and
1999, and followed up to mid-2002, one patient was reported to
have died from oesophageal cancer, and one from adenocarcinoma
without speciﬁcation of primary site (from a total of 23 deaths)
[15]. In a Danish cohort study including 2151 women hospitalised
with anorexia nervosa during 1970–1993 with follow-up to 31st
December 1996, one incident case of oesophageal cancer was
observed compared to around 0.1 expected, yielding a non-
signiﬁcant standardised incidence ratio (SIR) of 20 (95% conﬁdence
interval 0.5–111) [16].
We conducted a population-based data linkage study, aiming to
investigate the risk of oesophageal cancer among patients with a
prior history of hospitalisation with eating disorder.
2. Methods
2.1. Study population and oversight
Eating disorders represent a spectrum of conditions with
overlapping symptoms and behaviours [17]. The 10th revision of
the International Statistical Classiﬁcation of Diseases and Related
Health Problems (ICD-10), which is used currently to code Scottish
hospital and mortality records, identiﬁes several categories of
eating disorder, including anorexia nervosa (and atypical variant),
bulimia nervosa (and atypical variant), and other eating disorders,
including eating disorder unspeciﬁed [18]. Back-mapping to the
ninth revision of the International Classiﬁcation of Diseases (ICD-
9) is imperfect – although there is a speciﬁc code for anorexia
nervosa, bulimia nervosa has to be coded to a less speciﬁc category
[19] (See Appendix).
In Scotland, a national linked database of general hospital
discharge records, psychiatric hospital records, cancer registra-
tions, and mortality records has been established by probability
matching [20]. Estimates based on clerical checking suggest that
rates of false positive and false negative linkages are maintained
below 1% [21]. False positive and false negative links are likely to be
less common nowadays because of more widespread availability
and use of the Community Health Index (CHI) number, a unique
national identifying number used in health service records in
Scotland. We selected de-identiﬁed records of patients admitted
for the ﬁrst time to general or psychiatric hospitals between
1981 and 2011 with eating disorder as deﬁned by any mention, in
up to six discharge diagnosis ﬁelds, of the following diagnostic
codes: ICD-9 307.1 and/or 307.5 (1981–March 1996); ICD-10 F50
(April 1996 onwards). When a patient had more than one relevant
diagnostic code assigned, we based our selection on the earliest
admission or, if there was more than one diagnosis during that ﬁrst
hospital episode, on the diagnosis recorded in the highest position
on the discharge form. Since eating disorders are very rare in
children younger than 10 or adults older than 60 years of age [22],
the cohort was restricted to patients aged 10 years and <60 years
at the date of ﬁrst admission with eating disorder. This led to a
potential study cohort of 4419 individuals.
In Scotland, although socio-economic deprivation has been
associated with oesophageal cancer overall, the relationship
appears to vary by histological sub-type [23]. Historically, eating
disorders have been associated with high socio-economic status,although this relationship is not clear-cut, and an opposite
relationship may apply to bulimia nervosa [24]. As an indicator
of socio-economic position, based on postcode sectors of residence
at the time of original diagnosis, individuals were assigned to
population-weighted ﬁfths of Carstairs deprivation scores by
applying 1991 and 2001 census-derived Carstairs scores to the
periods of diagnosis 1981–1995 and 1996–2011, respectively. The
Carstairs deprivation index is based on small area of residence, and
is derived from four variables collected at each decennial census:
social class, unemployment, overcrowding, and car ownership
[25].
The study was approved by the Privacy Advisory Committee of
the National Health Service (NHS) National Services Scotland
(NSS).
2.2. Outcome data
The incidence of oesophageal cancer (ICD-9 150; ICD-10 C15)
was the main outcome of interest. Related outcomes included the
incidence of oesophageal adenocarcinoma and oesophageal
squamous cell carcinoma (both based on speciﬁc ICD-O morphol-
ogy codes deﬁned by the International Agency for Research on
Cancer) [26], and the incidence of gastric cancer (ICD-9 151; ICD-
10 C16) and cancer of the gastric cardia (ICD-9 151.0; ICD-10
C16.0), since there is the potential for misclassiﬁcation of tumours
arising in the vicinity of the oesophago-gastric junction.
In the absence of individual data on smoking and alcohol use in
our study population, we sought to assess the potential
confounding effect of these risk factors indirectly, by investigating
additionally the incidence of lung cancer (ICD-9 162; ICD-10 C33-
C34), ﬁrst hospitalisation with chronic obstructive pulmonary
disease (COPD: ICD-9 490–492, 496; ICD-10 J40–J44), and ﬁrst
hospitalisation associated with alcohol-related diagnoses (as
deﬁned in a previous publication [27]). See the Appendix for a
full list of the diagnostic codes used to deﬁne eating disorders and
outcomes.
2.3. Statistical analysis
Study subjects with any of these pre-speciﬁed outcomes
(selected cancers, COPD, or alcohol-related diagnoses) prior to
the date of their ﬁrst recorded admission with eating disorder
(n = 410; 9.3%) were excluded. In addition, to try and exclude
patients with outcome-related symptoms, such as anorexia, that
were originally misdiagnosed/misclassiﬁed/miscoded as eating
disorders, we excluded the person-time and outcomes (cancers or
hospitalisations) in the ﬁrst year of follow-up after ﬁrst hospital
admission with eating disorder. This led to the exclusion of
322 persons (7.3%) who had a diagnosis of gastric cancer (n = 2),
COPD (n = 8), alcohol-related conditions (n = 266), COPD and
alcohol-related conditions (n = 1), or died (n = 45) within the ﬁrst
year of follow-up. Finally, 70 individuals were excluded because it
was not possible to assign them to a deprivation category. After
these exclusions, the study cohort included 3617 (82%) individuals.
For the analysis of oesophageal, gastric and lung cancer incidence,
follow-up was from 1 year after the earliest date of hospital
admission with eating disorder to date of one of these incident
cancers, date of death, or end of 2012, whichever occurred ﬁrst. For
the end-points of hospitalisation (COPD or alcohol-related),
follow-up was from 1 year after the earliest date of hospital
admission with eating disorder to date of ﬁrst hospital admission
(COPD or alcohol-related), date of death, or end of 2012, whichever
occurred ﬁrst.
Indirectly standardised incidence/hospitalisation ratios (SIRs/
SHRs) and absolute excess risks (AERs) were calculated, using the
general population as a reference group to generate expected
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calendar period-speciﬁc rates of disease). Rates were calculated
using decennial census-based, mid-year population estimates
sourced from the General Register Ofﬁce for Scotland (now part of
National Records of Scotland). SIRs/SHRs were calculated as the
ratio of observed to expected numbers of cases. AERs were
calculated as the observed minus the expected number of cases
divided by the number of person-years at risk and expressed as the
rate per 10,000 person-years at risk. The AER reﬂects the additional
absolute burden of disease beyond background rates. 95%
conﬁdence intervals for SIRs/SHRs and AERs were calculated by
assuming that the observed numbers of events followed a Poisson
distribution.
3. Results
3.1. Characteristics of the study population
The distribution and summary characteristics of the study
population are shown in Table 1. Data are not shown separately for
patients with bulimia nervosa (n = 427; 93% females) because it
was only possible to identify such patients from April 1996 on-
wards, when ICD-10 replaced ICD-9 for classiﬁcation and coding of
hospital records in Scotland.
The majority of the cohort (90%) was female, and more than 75%
had their ﬁrst admission with eating disorder before the age of
30 years. Overall, there was a tendency for more patients to be
assigned to the least deprived ﬁfth (21%) compared with the most
deprived ﬁfth (19.2%) of the population, although this trend was
reversed among patients with eating disorders other than anorexia
nervosa, especially in those with bulimia nervosa (15.7% vs 22.5% –
patients recorded from April 1996 onwards as explained above,Table 1
Distribution and summary characteristics of the study population.
Males Females Persons
Number % Number % Number %
Age-group (years) at ﬁrst admission with eating disorder
10–19 163 46.6 1346 41.2 1509 41.7
20–29 96 27.4 1183 36.2 1279 35.4
30–39 46 13.1 465 14.2 511 14.1
40–49 27 7.7 191 5.8 218 6.0
50–59 18 5.1 82 2.5 100 2.8
Deprivation ﬁfth
1 – Least deprived 73 20.9 687 21.0 760 21.0
2 67 19.1 686 21.0 753 20.8
3 68 19.4 669 20.5 737 20.4
4 64 18.3 608 18.6 672 18.6
5 – Most deprived 78 22.3 617 18.9 695 19.2
Type of eating disorder
Anorexia nervosa (AN) 161 46.0 1977 60.5 2138 59.1
All eating disorders
except AN
189 54.0 1290 39.5 1479 40.9
Total 350 9.7 3267 90.3 3617 100
Males Females Persons
Mean age at study entry
(years)
24.0 23.8 23.8
Median calendar year at study
entry
1997 1997 1997
Median number of years of
follow-up
14.0 13.9 13.9
Person-years at risk 5167 47,288 52,455
Number of oesophageal cancers
diagnosed during follow-up
0 7 7
Mean age at diagnosis of
oesophageal cancer
N/A 55.6 55.6
N/A: not applicable.underlying data available on request). Just over 60% of females
were classiﬁed as having anorexia nervosa, compared with only
46% of males. The mean age at study entry was around 24 years,
and the median calendar year at study entry was 1997. Patients
were followed up for a median of 13.9 years (mean 14.5 years),
corresponding to 52,455 person-years at risk. Seven oesophageal
cancers were diagnosed during follow-up, all arising in females at a
mean age of 55 years (range 35–72).
Table 2 shows the risks of the pre-speciﬁed outcomes, stratiﬁed
by category of eating disorder.
3.2. Risks of oesophageal and gastric cancer
Based on seven cases observed and 1.14 expected, the
standardised incidence ratio (SIR) for oesophageal cancer in the
entire cohort was 6.1 (95% conﬁdence interval: 2.5–12.6),
corresponding to an absolute excess risk of 1.1 per 10,000
person-years at risk (95% CI: 0.32–2.52). All of the oesophageal
cancers were coded as squamous cell carcinoma, and all arose in
women classiﬁed as having had anorexia nervosa. These seven
individuals were ﬁrst hospitalised with anorexia nervosa between
1981 and 1984 (although it is possible that some were admitted
prior to the calendar period of the linked data available to us). They
developed their oesophageal cancers between 2000 and 2011, after
a mean interval of 22 years (range 19–28 years). The risks of gastric
cancer and gastric cardia cancer were increased, but the estimates
were very imprecise.
3.3. Risks of lung cancer, COPD, and alcohol-related conditions
The risk of lung cancer was increased slightly, but the
conﬁdence interval was wide. However, standardised hospitalisa-
tion ratios (SHRs) for COPD and especially for alcohol-related
conditions were increased signiﬁcantly across all categories of
eating disorder, with a tendency to be higher in ‘all eating disorders
except anorexia nervosa’. SHRs were particularly increased in
patients classiﬁed as bulimia nervosa: 4.1 (1.3–9.5) for COPD and
7.5 (5.7–9.7) for alcohol-related conditions (data not shown in
Table 2, but available on request).
4. Discussion
We found a signiﬁcant 6-fold increased risk of oesophageal
cancer in this cohort of patients previously hospitalised with eating
disorder. However, the conﬁdence interval is wide, reﬂecting the
relatively modest size of the study population, its relatively young
age proﬁle, limited duration of follow-up, and consequently the
small number of oesophageal cancers diagnosed (also reﬂected by
a low absolute excess risk).
Surveillance bias seems unlikely to explain our ﬁndings for two
reasons. Firstly, oesophageal cancer is unlikely to remain undiag-
nosed for long, even in patients who are not in regular contact with
health services. Indeed, it often results in death within less than a
year of diagnosis. Secondly, although surveillance bias might be
expected to exert its greatest impact during early years of follow-
up, all of the cases of oesophageal cancer emerged at least 19 years
after the ﬁrst admission with eating disorder.
Even if our ﬁndings are valid, the relatively low lifetime
prevalence of eating disorders [17] suggests that they are unlikely
to contribute substantially to the population burden of oesopha-
geal cancer. However, there is some evidence that the incidence of
eating disorders is increasing over time [28], and it is still
important for these patients and their clinicians to be aware that
they may be at increased risk of oesophageal cancer later in life,
with a view to achieving earlier investigation and diagnosis
following the onset of any relevant symptoms or signs.
Table 2
Risks (standardised incidence/hospitalisation ratios and absolute excess risks) of selected outcomes by category of eating disorder.a
Outcome Observed
number of
events (O)
Person years
at risk (PYAR)
Expected
number of
events (E)
Standardised
incidence/
hospitalisation
ratio (SIR/SHR)a
95% conﬁdence
interval
Absolute excess
risk (AER) per
10,000 PYAR
95% Conﬁdence
interval
Lower Upper Lower Upper
All eating disorders combined
Oesophageal cancer 7 52,455 1.14 6.12 2.46 12.60 1.12 0.32 2.52
Adenocarcinoma 0 52,462 0.46 0.00 0.00 8.02 N/A N/A N/A
Squamous cell carcinoma 7 52,455 0.57 12.21 4.91 25.15 1.23 0.42 2.62
Gastric cancer 3 52,457 1.50 2.00 0.41 5.84 0.29 0.17 1.38
Gastric cardia cancer 1 52,461 0.31 3.19 0.08 17.77 0.13 0.05 0.99
Lung cancer 11 52,454 8.93 1.23 0.62 2.20 0.39 0.65 2.04
COPD hospital admission 61 52,190 31.61 1.93 1.48 2.48 5.63 2.91 8.96
Alcohol-related hospital admission 412 48,743 112.31 3.67 3.32 4.04 61.48 53.46 70.05
Anorexia nervosa (AN)
Oesophageal cancer 7 35,919 0.70 9.96 4.00 20.51 1.75 0.58 3.80
Adenocarcinoma 0 35,926 0.27 0.00 0.00 13.66 N/A N/A N/A
Squamous cell carcinoma 7 35,919 0.37 19.06 7.66 39.27 1.85 0.69 3.94
Gastric cancer 1 35,924 0.98 1.02 0.03 5.69 0.01 0.26 1.28
Gastric cardia cancer 0 35,926 0.19 0.00 0.00 19.42 N/A N/A N/A
Lung cancer 7 35,919 5.76 1.22 0.49 2.51 0.35 0.82 2.42
COPD hospital admission 32 35,795 20.96 1.53 1.04 2.16 3.08 0.23 6.79
Alcohol-related hospital admission 230 33,650 74.26 3.10 2.71 3.52 46.28 37.74 55.61
All eating disorders except AN
Oesophageal cancer 0 16,536 0.44 0 0.00 8.38 N/A N/A N/A
Adenocarcinoma 0 16,536 0.19 0 0.00 19.42 N/A N/A N/A
Squamous cell carcinoma 0 16,536 0.21 0 0.00 17.57 N/A N/A N/A
Gastric cancer 2 16,533 0.52 3.84 0.46 13.87 0.90 0.17 4.05
Gastric cardia cancer 1 16,535 0.12 8.31 0.21 46.30 0.53 0.06 3.29
Lung cancer 4 16,535 3.17 1.26 0.34 3.23 0.50 1.27 4.28
COPD hospital admission 29 16,395 10.65 2.72 1.82 3.91 11.19 5.33 18.90
Alcohol-related hospital admission 182 15,094 38.05 4.78 4.11 5.53 95.37 78.40 114.20
N/A: not applicable.
a Indirectly standardised for age, sex, calendar period of follow-up, and deprivation.
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eating disorders are at higher than expected risk of oesophageal
adenocarcinoma caused by self-induced vomiting practiced as a
method of weight control. None of the cancers diagnosed were
classiﬁed as adenocarcinomas. Furthermore, the risk of oesopha-
geal cancer was conﬁned to women with a history of anorexia
nervosa who may be less inclined to indulge in self-induced
vomiting [2]. However, it may be premature to rule out an
increased risk of oesophageal adenocarcinoma entirely, in the face
of limited statistical power.
It is also worth considering the possibility that self-induced
vomiting could cause chronic physical damage to oesophageal
mucosa through repeated microtrauma, rather than chemical
damage caused by gastric acid. For example, another type of
physical damage, thermal injury, has been associated with
subsequent increased risk of oesophageal cancer (and speciﬁcally
squamous cell carcinoma [29]) in some studies [30].
However, the most likely explanation for our ﬁndings would
seem to be confounding by the main established risk factors for
oesophageal squamous cell carcinoma, namely tobacco and
alcohol, perhaps compounded by chronic nutritional deﬁciency
[6]. Malnutrition and insufﬁcient intake of micronutrients
certainly occur in people with eating disorders [7], but despite
evidence of alterations in cell-mediated immunity, adaptation
processes seem to occur enabling immune function to bepreserved during long periods of the illness [31]. Nevertheless,
there is evidence that nutritional deﬁciency is positively
associated with oesophageal cancer [6], and it is conceivable
that prolonged periods of nutritional deﬁciency could increase
susceptibility to other carcinogenic risk factors, such as tobacco
and alcohol.
As noted previously, patients with eating disorders seem to be
susceptible to smoking [3] and alcohol use disorders [4,5], and this
also seems to be borne out by our analysis of hospitalisation for
relevant associated conditions (COPD and alcohol-related condi-
tions). The fact that smoking and alcohol use disorders seem to be
more common in patients with eating disorders with features
other than restrictive anorexia nervosa [3,5] (also borne out, to
some extent, by our results), is not really consistent with our
ﬁnding that the oesophageal cancers were restricted to patients
with anorexia nervosa. However, this may simply be a reﬂection of
the smaller number of patients classiﬁed with eating disorders
other than anorexia nervosa. Moreover, it is important to
remember that there is considerable overlap of characteristics
between various types of eating disorders [17]. For example, the
ICD-10 deﬁnition of bulimia nervosa (F50.2) states that ‘‘There is
often, but not always, a history of an earlier episode of anorexia
nervosa, the interval ranging from a few months to several years’’
[18]. Against this background, it is also important to remember
that we assigned the diagnosis of eating disorder based on the
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that ﬁrst hospital episode, on the diagnosis recorded in the highest
position. At the same time, it may be unrealistic to expect hospital
administrative data collected routinely and coded to successive
editions of the International Classiﬁcation of Diseases to capture
the intricacies of the various sub-categories of eating disorders,
which have themselves altered over time.
In a Swedish cohort study of 6009 women hospitalised with
anorexia nervosa between 1973 and 2003 with follow-up to 31st
December 2003, the SIR for cancer of digestive organs was 1.4
(0.6–2.7) based on eight cases [32]. A further breakdown of these
cases was not provided on the grounds of inadequate statistical
power. While these results do not support our main ﬁnding, it is
possible that they could conceal an excess risk of oesophageal
cancer if there was a deﬁcit of other digestive tract cancers. For
example, the Danish cohort study mentioned previously [16]
reported a very similar SIR for cancer of digestive organs (SIR 1.3,
0.3–3.9) based on three cases, although none of these was a
colorectal cancer, perhaps reﬂecting higher than average rates of
physical activity among patients with eating disorders [33]. While
the risk of oesophageal cancer was spectacularly high (SIR 20), it
was based on just a single case, with a very wide 95% conﬁdence
interval (0.5–111). It may be that there is greater scope to detect
an excess risk in Scotland, where the world age-standardised
incidence rate of oesophageal cancer among women was 4.6 per
100,000 during 2003–2007 compared with 2.1 in Denmark and
1.0 in Sweden [34].
Like previous cohort studies in Denmark [16] and Sweden [32],
our study can be regarded as population-based in the sense that
the data cover all publically provided healthcare, and private
provision of mental health services in Scotland is negligible.
However, by restricting our study to hospitalised patients, who are
likely to occupy the more severe end of the eating disorders
spectrum, we may have over-estimated the relative risk of
oesophageal cancer associated with eating disorders.
In Scotland, general hospitalisation data are supported by an
active programme of quality assurance including regular assess-
ments of data quality. In relation to discharges from general
hospitals, the accuracy of coding of main diagnosis has been
estimated to be around 88% overall and has been relatively stable
for at least 20 years [35]. Less evidence is available on which to
base an assessment of the quality of psychiatric hospital data.
However, as noted previously, many features of our study
population seem to be consistent with those reported from more
detailed, albeit smaller studies of patients with various categories
of eating disorders [3–5,17,24].
Based on routinely available indicators [34], and speciﬁc studies
of completeness of case ascertainment [36] and data reliability
(including the coding of tumour morphology) [37], the quality of
cancer registration data in Scotland is believed to be comparatively
high. There is corroborating evidence for the registered oesopha-
geal cancers included in our study in the sense that all the patients
are deceased and have their underlying cause of death also coded
as oesophageal cancer.
A further strength of our study was the ability to standardise for
socio-economic deprivation, which has been associated both with
eating disorders [24] and oesophageal cancer [23] in some studies.
However, it must be acknowledged that our indicator of
deprivation has limitations because it refers to a single point in
time, is based on area of residence rather than individual
characteristics, and is based on census data that are only updated
every 10 years.
As pointed out previously, and in common with other studies,
the two main weaknesses of our study are limited statistical
power, and a lack of information on potential confoundingfactors at individual level. A further weakness is that, particularly
for patients hospitalised with eating disorders in the early 1980s,
we may not have identiﬁed the earliest date of hospitalisation
because the linked data available to us did not extend back before
1981. As a result, we may have under-estimated person-years at
risk and therefore expected numbers of cases, leading to an over-
estimation of risk. However, the impact of this potential artefact
seems likely to be small because the missing person-years are
likely to be concentrated at the younger end of the age range,
when the risk of oesophageal cancer is very low. Even in the data
available to us, we found that the expected number of
oesophageal cancers was very low during early years of
follow-up (0.06 up to <10 years after admission with eating
disorder). Lastly, another minor weakness is that we were not
able to identify emigrants from Scotland who will have been lost
to follow-up.
In summary, our results suggest that women with a past
history of eating disorder (speciﬁcally anorexia nervosa) are at
increased risk of squamous cell carcinoma of the oesophagus.
This may be explained by concomitant alcohol use disorder and
smoking, possibly aggravated by nutritional deﬁciencies. Our
data do not support the hypothesis that patients with eating
disorders are at higher than expected risk of oesophageal
adenocarcinoma caused by self-induced vomiting practiced as a
method of weight control. Our ﬁndings need to be replicated,
ideally in a larger study population with longer follow-up and
information on potential confounding factors at an individual
level. In the meantime, irrespective of causal mechanisms, it
may be sensible for physicians to exercise a high index of
suspicion in patients with a past history of eating disorder who
present with symptoms that might suggest a diagnosis of
oesophageal cancer.
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Appendix. Diagnostic codes used to identify ‘exposure’ (eating disorders) and outcomes
All eating disorders combined
ICD-9 307.1, 307.5; ICD-10 F50
Anorexia nervosa (AN)
ICD-9 307.1; ICD-10 F50.0, F50.1
All eating disorders except AN
ICD-9 307.5; ICD-10 F50.2, F50.3, F50.4, F50.5, F50.8, F50.9
Bulimia nervosa (BN)
ICD-10 F50.2, F50.3
ICD-9 code Diagnostic term ICD-10 code Diagnostic term
307.1 Anorexia nervosa F50.0 Anorexia nervosa
307.5 Other and unspeciﬁed disorders of eating F50.1 Atypical anorexia nervosa
F50.2 Bulimia nervosa
F50.3 Atypical bulimia nervosa
F50.4 Overeating associated with other psychological disorders
F50.5 Vomiting associated with other psychological disturbances
F50.8 Other eating disorders
F50.9 Eating disorder, unspeciﬁed
Oesophageal cancer (main outcome)
ICD-9 150; ICD-10 C15
Oesophageal adenocarcinoma
ICD-9 150; ICD-10 C15 in conjunction with ICD-O morphology codes 8140–8141, 8143–8145, 8190–8231, 8260–8263, 8310, 8401,
8480–8490, 8550–8551, 8570–8574, 8576
Oesophageal squamous cell carcinoma
ICD-9 150; ICD-10 C15 in conjunction with ICD-O morphology codes 8050–8078, 8083–8084
Gastric cancer
ICD-9 151; ICD-10 C16
Gastric cardia cancer
ICD-9 151.0; ICD-10 C16.0
Lung cancer
ICD-9 162; ICD-10 C33-C34
Chronic obstructive pulmonary disease (COPD)
ICD-9 code ICD-10 code Condition
490 J40 Bronchitis, not speciﬁed as acute or chronic
J41 Simple and mucopurulent chronic bronchitis
491 J42 Unspeciﬁed chronic bronchitis
492 J43 Emphysema
496 J44 Other chronic obstructive pulmonary disease
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Alcohol-related diagnoses
ICD-9 code ICD-10 code Condition
E244 Alcohol induced Pseudo-Cushing’s syndrome
E512 Wernicke’s encephalopathy
291
303
F10 Mental and behavioural disorders due to use of alcohol
G312 Degeneration of nervous system due to alcohol
3575 G621 Alcoholic polyneuropathy
G721 Alcoholic myopathy
4255 I426 Alcoholic cardiomyopathy
5353 K292 Alcoholic gastritis
5710
5711
5712
5713
K70 Alcoholic liver disease
K860 Alcohol-induced chronic pancreatitis
O354 Maternal care for (suspected) damage to foetus from alcohol
7903 R780 Finding of alcohol in blood
9800 T510 Toxic effect of ethanol
9801 T511 Toxic effect of methanol
3050
9809
T519 Toxic effect of alcohol, unspeciﬁed
E860 X45 Accidental poisoning by and exposure to alcohol
X65 Intentional self-poisoning by and exposure to alcohol
Y15 Poisoning by and exposure to alcohol undetermined intent
E9473 Y573 Alcohol deterrents
Y90 Evidence of alcohol involvement determined by blood alcohol level
Y91 Evidence of alcohol involvement determined by level intoxication
Z502 Alcohol rehabilitation
Z714 Alcohol abuse counselling and surveillance
Z721 Alcohol use
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